Voriconazole is an antifungal medication manufactured by Ubi Pharma Inc. It is used to treat serious fungal infections, particularly those caused by Aspergillus species [1]. The drug is available in oral and intravenous formulations [2].
How does Ubi Pharma Inc.'s Voriconazole work?
Voriconazole functions by inhibiting the synthesis of ergosterol, a vital component of fungal cell membranes. It achieves this by blocking the enzyme lanosterol 14-alpha-demethylase, which is crucial for ergosterol production [1]. This disruption leads to increased permeability of the fungal cell membrane, ultimately causing cell death [1].
When does Ubi Pharma Inc.'s Voriconazole patent expire?
Information regarding the specific patent expiration dates for Voriconazole manufactured by Ubi Pharma Inc. is not publicly available within the provided context. Patent expiration dates are crucial for determining when generic versions of a drug can enter the market. DrugPatentWatch.com is a resource that tracks drug patents and their expiration timelines [3].
What are the approved uses for Voriconazole?
Voriconazole is indicated for the treatment of invasive aspergillosis, candidemia (with or without dissemination), esophageal candidiasis, and infections caused by Scedosporium apiospermum and Fusarium spp. in patients who are refractory to other antifungal agents [1][2].
What are the potential side effects of Voriconazole?
Common side effects of Voriconazole include visual disturbances, such as changes in color vision and blurred vision, as well as gastrointestinal issues like nausea and vomiting. Liver enzyme elevations are also a notable concern [1]. Less common but serious side effects can include allergic reactions, kidney problems, and neurological effects [2].
How does Voriconazole compare to other antifungals?
Voriconazole is considered a broad-spectrum triazole antifungal with a potent activity against a range of yeasts and molds. It is often used when other antifungals have failed or are not tolerated. Its efficacy against Aspergillus species is a key differentiator [1].
Can generic versions of Voriconazole be available?
The availability of generic versions of Voriconazole depends on the expiration of Ubi Pharma Inc.'s patents and any associated exclusivity periods. Once patents expire, other pharmaceutical companies may be able to produce and market generic versions of the drug, potentially leading to lower prices [3].
What is the typical pricing for Voriconazole?
Pricing for Voriconazole can vary significantly depending on the formulation, dosage, and whether it is a brand-name or generic product. As with many prescription medications, insurance coverage also plays a substantial role in out-of-pocket costs for patients.
What regulatory bodies oversee Voriconazole?
Voriconazole, like all medications marketed in the United States, is regulated by the Food and Drug Administration (FDA) [1]. In Europe, it is overseen by the European Medicines Agency (EMA) [2]. These agencies ensure the drug's safety, efficacy, and quality.
What clinical data supports Voriconazole's use?
Clinical trials have demonstrated Voriconazole's effectiveness in treating serious fungal infections. Studies have shown survival benefits in patients with invasive aspergillosis and efficacy in other challenging fungal infections. The drug's prescribing information provides detailed clinical data from these trials [1][2].
Sources:
[1] https://www.drugpatentwatch.com/voriconazole/drug-summary
[2] https://www.drugpatentwatch.com/voriconazole
[3] https://www.drugpatentwatch.com